JAIME SMOLIK: Open Payments
NPI 1295722791 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| GENZYME CORPORATION | 2 | $47 |
| Genentech USA, Inc. | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| CSL Behring | 1 | $14 |
Products named: JOURNAVX, TEZSPIRE, Xolair, FASENRA, AYVAKIT, NEMLUVIO, Hizentra.
Industry payments across IA — which companies pay providers there.
